HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$0.80
Day range
$0.77 - $0.82
Year range
$0.54 - $4.10
Market cap
8.40M USD
Avg Volume
1.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.38M | -6.16% |
Net income | -3.11M | 8.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.53M | -60.61% |
Total assets | 4.32M | -36.07% |
Total liabilities | 1.32M | -71.66% |
Total equity | 3.00M | — |
Shares outstanding | 10.64M | — |
Price to book | 1.60 | — |
Return on assets | -147.75% | — |
Return on capital | -216.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.11M | 8.71% |
Cash from operations | -3.68M | -34.34% |
Cash from investing | — | — |
Cash from financing | 977.00K | — |
Net change in cash | -2.70M | 1.39% |
Free cash flow | -2.62M | -56.52% |
About
Founded
1965
Headquarters
Website
Employees
1
